Wilmington Savings Fund Society FSB Decreases Stock Position in Solventum Co. (NYSE:SOLV)

Wilmington Savings Fund Society FSB decreased its holdings in shares of Solventum Co. (NYSE:SOLV) by 4.7% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 16,263 shares of the company’s stock after selling 799 shares during the period. Wilmington Savings Fund Society FSB’s holdings in Solventum were worth $1,074,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. Sanctuary Advisors LLC acquired a new position in shares of Solventum in the second quarter valued at about $516,000. Mather Group LLC. acquired a new position in Solventum in the 3rd quarter worth approximately $27,000. CWM LLC raised its position in Solventum by 60.3% during the 3rd quarter. CWM LLC now owns 14,329 shares of the company’s stock worth $999,000 after buying an additional 5,390 shares during the last quarter. Exchange Traded Concepts LLC acquired a new stake in Solventum during the 3rd quarter valued at approximately $60,000. Finally, CHICAGO TRUST Co NA purchased a new stake in shares of Solventum in the 3rd quarter valued at $313,000.

Wall Street Analysts Forecast Growth

SOLV has been the subject of several recent research reports. Piper Sandler raised their target price on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Morgan Stanley lifted their price objective on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Finally, Mizuho initiated coverage on Solventum in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 target price on the stock. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Solventum presently has an average rating of “Hold” and an average target price of $68.29.

Solventum Price Performance

Shares of SOLV opened at $74.29 on Tuesday. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05. The stock’s 50 day moving average is $70.40 and its two-hundred day moving average is $68.09. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.